Drug Type Synthetic peptide |
Synonyms BNZ-132-3 |
Target |
Mechanism IL-15 inhibitors(Interleukin-15 inhibitors), IL-21 inhibitors(Interleukin-21 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Phase 1 | US | - | |
Autoimmune Diseases | Preclinical | US | - |